$EAC- $DRRX – TOTAL PROFIT OF $305 BUT LEFT $125 ON THE TABLE!

AAAAHHH…… That’s how you feel after you take a dump! That’s how I felt after I dumped these shares of $EAC and $DRRX.

DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms. Their drug Remoxy is their leading candidate who has been rejected twice by the FDA.

Pfizer ($PFE) is the commercialization partner for Durect. Today Pfizer had their earnings conference call. The conference call would be a good time for Pfizer to mention if DRRX would go a round three with the FDA. Sure enough they seem to be taking steps in that direction.

Remoxy is a drug that addresses a genuine medical need as a tamper-resistant re-formulation of oxycodone given the prevalence of prescription opioid. It is formulated with Durect’s Oradur technology to prevent the painkiller from being crushed and used for inhalation or injection. Dissolving or heating the medication does not cause rapid release of the drug either. – Basileus from Seeking Alpha-

If this drug got approved it would be a blockbuster drug. The technology is one of a kind and would prevent abuse of the drug with its tamper resistant formulation. The market potential could be up to 1.5 Billion. I bought 500 shares of $DRRX on Friday April 26th for a swing or run up into the conference call for Pfizer earnings. I attended the conference call today but unfortunately they did not mention anything about Remoxy until the Q&A started and one of the attendees asked the CEO about the next steps for Remoxy. Sure enough they said “we are taking forward steps” to basically iron out the details that the FDA is looking for. As soon as they said that the stock sky rocketed! It reached a high of 1.85.

Here is a screen shot of the chart today and my trade. I bought 500 at 1.33 and sold at 1.50. I wanted to get out at 1.75 but there was a big pull back and could not get filled. Still a profit is a profit!

$EAC

Erickson Air Crane was my second trade today. I bought 100 shares last week when it pulled back at $17.68. I would of bought more but I did not have the buying power. @super_trades gave this one in the 17’s and also has a seeking alpha article on it which you can see here. He has this stock going to $30 plus , he is always consistent on his trades, one of the best I know! This was a swing trade for me and I look to get back into this one soon.

So far a good week! If I would of sold DRRX at 1.75 that would of been a extra $125 for a total of $430 today but I came out with $305 and I’am cheesin!

Trade Breakdowns:

DRRX

April 26th Bought 500 shares at 1.33

April 30th sold 500 at 1.50

Profit= $85

EAC

April 24th bought 100 shares at 17.68

April 30th sold 100 shares at 19.88

Profit = $220

God Bless America!

Good Morning America! I have not been able write a new article lately with so many things going on. Last week was insane, with the Boston Bombings, poison letter to the president, Texas plant explosion and bombings in India. My thoughts are prayers go out to all people who were involved in any kind of tragedy, be safe and keep calm and carry on.

For me last week was a slow trading week. I had bought EAC (Erickson Air Crane on Monday April 15th 100 shares at 19.85) If you do your research this company is going through a big acquisition with revenues that will double. After the acquisition share price could reach $30 plus. I sold my puny 100 shares on Friday April 19th right before the breakout! I made $5 bucks because I got impatient, if I would of held I would of made a nice profit of $120 plus. Today the price is down, maybe just a pullback but it will rebound and continue its climb higher ..imo.

Also, I just finished Steve Nison’s Vol. 1 DVD for Candlestick charting. Vol. 1 is 4 hours of learning different candlestick patterns. I would definitely recommend this to anyone who wants to gain more knowledge of how to read and understand candlesticks and technical analysis. The most important thing I learned was how to look for a signs of reversal patterns. I think this alone can help you enter and exit trades very precisely……after all…Timing is everything!

Learn Candlestick Charting here:

ROYL – NOT QUITE CASINO ROYALE BUT PROFIT OF $90

Holy shit!

That’s exactly what everyone said when they saw this stock rip from $2.10 to $3.48 in 45 minutes. On Wednesday April 10th around 3:15 pm Royale Energy announced a $43 Million dollar venture with a Alaska North Slope Holdings. As soon as this news hit the internet the stock went looney tunes!

If you look at the past three months this stock has not had much movement and was on a downward trend. This is big news  for the company. As for me, I did some research on ROYL after the market closed. The company has debt and operating at a loss right now but that’s not going to stop traders. News like this is going to push the stock up, this morning  it was getting some action in pre-market so I knew it would surge again. Also, I am sure a lot of people didn’t hear the news until after the market closed since the news came late in the day around 3:15 pm. A lot of people didn’t get their piece of the pie 😎

Since the stock was already up so high I knew there would be short sellers so I waited a few minutes after the open to let the stock drop and wait for the bounce. It opened at $3.20 and fell to $3. I got in at $3.12. I bought 500 shares because of the volatility, sold at $3.30.

Here is a screen shot of the chart,…. straight off my trading platform… did all this at work by the way!

You can see it was trading flat ….then BOOM!

Royale Energy announces $43M Alaskan joint venture
Royale Energy announced that it has signed a letter of intent to receive $100 per acre in cash, plus other consideration including stock options and exploration cost sharing for a total of over $1,200 per acre for up to 50,875 acres of its 96,000 acre Alaska North Slope holdings. An undisclosed company has agreed in principal to fund all exploration costs for seismic data acquisition and the drilling of two horizontal wells for a total of $38M. Additionally Royale will receive $3.37M for the 33,736.59 acres on the company’s Western Block, together with stock options and a right to receive an additional $1.7M for 17,000 acres in the company’s Central Block. The transaction is subject to consummation of a final agreement setting forth the detailed terms of investment and the exploration of the property. The prospective agreement is still under negotiation between the parties and is expected to be completed on or before May 30 this year, the company said.

Article Link: ROYL VENTURE

TRADE INFO:

Entry: 500 shares @ 3.12

Exit: 500 shares @ 3.30

Profit = $90 dollars in about 8 minutes

BCRX – PROFIT OF $126 IN 60 SECONDS!

If you haven’t been watching the news lately… let me update you. China had a flu outbreak that killed several people and are trying to find out where its coming from and why its infecting humans. Below is the article on the outbreak and BioCryst Pharmaceuticals (BCRX)

Because of the outbreak China’s FDA tried to expedite the approval of Peramivir(a flu vaccine that BCRX has in its Phase 3 stage) Because of this news the stock jumped, in three trading days the stock went from 1.26 to 2.20. On Monday April 8th BCRX was trading heavily pre-market close to a million shares. After the market opened I bought 700 shares at 2.02 and the price jumped in less than 60 seconds to a high of 2.21. I sold at 2.20.

 

Shares of flu treatment developer BioCryst Pharmaceuticals Inc. soared Monday morning as concern continued to grow about a new strain of bird flu emerging in China

THE SPARK: A bird flu strain labeled H7N9 that has never before been found in humans has sickened at least 24 people in eastern China, killing seven of them.

Officials say they do not know why the virus is infecting humans now. It has been detected in live poultry in several food markets where human cases have been found, leading officials to think people are most likely contracting the virus through direct contact with infected fowl.

There’s no evidence so far that the virus is spreading easily between people, but scientists are watching closely to see if the flu poses a substantial risk to public health or could potentially spark a global pandemic.

THE BIG PICTURE: BioCryst, based in Durham, N.C., is developing an intravenous anti-viral agent named peramivir that aims to treat the flu.

On April 1, the company said it received a letter from the U.S. Food and Drug Administration that outlines an approach the company could take in applying to have the drug approved and ultimately sold in the United States.

THE ANALYSIS: WBB Securities analyst Steve Brozak said the stock’s rise is tied to the bird flu concerns. But he noted that it remains to be seen whether BioCryst’s treatment is effective against the current strain. He said the stock also has risen in recent years when other flu scares surfaced.

“Every time something comes up like this, the stuck runs,” he said. “It’s ‘gather up the usual suspects.'”

SHARE ACTION: Up 35 cents, or nearly 21 percent, to $2.05 in late-morning trading, while broader trading indexes fell slightly. Company shares have climbed 44 percent since closing 2012 at $1.42.

 

 

TRADE INFO:

Shares: 700

Entry: 2.02

Exit:  2.20

Profit: $126

*I have not included commission fees on any trades yet. I will post a page on this and show how much I have spent on commission YTD